Page last updated: 2024-09-03

fullerene c60 and Graft vs Host Disease

fullerene c60 has been researched along with Graft vs Host Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernardes, PT; Castor, MG; De Paula, TP; Gonçalves, WA; Pinheiro, MV; Pinho, V; Reis, AC; Resende, CB; Rezende, BM; Souza, DG; Teixeira, MM; Vieira, EG	1

Other Studies

1 other study(ies) available for fullerene c60 and Graft vs Host Disease

Article	Year
Nanocomposite treatment reduces disease and lethality in a murine model of acute graft-versus-host disease and preserves anti-tumor effects. PloS one, 2015, Volume: 10, Issue:4 Topics: Animals; Antineoplastic Agents; Bone Marrow Transplantation; Cell Line, Tumor; Disease Models, Animal; Fullerenes; Graft vs Host Disease; Inflammation; Liver; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nanocomposites; Neutrophils; Reactive Oxygen Species	2015

Article

Year

Nanocomposite treatment reduces disease and lethality in a murine model of acute graft-versus-host disease and preserves anti-tumor effects.

PloS one, 2015, Volume: 10, Issue:4

Topics: Animals; Antineoplastic Agents; Bone Marrow Transplantation; Cell Line, Tumor; Disease Models, Animal; Fullerenes; Graft vs Host Disease; Inflammation; Liver; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nanocomposites; Neutrophils; Reactive Oxygen Species

2015